IA
RPRX

IFP Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

IFP Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12
Closed – – 4310
2018
Q1 		$0 Hold
12
– – ﹤0.01% 3944
2017
Q4 		$0 Hold
12
– – ﹤0.01% 4448
2017
Q3 		$0 Hold
12
– – ﹤0.01% 4449
2017
Q2 		$0 Hold
12
– – ﹤0.01% 4439
2017
Q1 		$0 Hold
12
– – ﹤0.01% 4381
2016
Q4 		$0 Buy
+12
New +$21 ﹤0.01% 4368
2016
Q3 		– Sell
-160
Closed – – 4300
2016
Q2 		$0 Buy
+160
New +$307 ﹤0.01% 4345

IFP Advisors's RPRX Position: Q2 2018 in Review

IFP Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q2 2018, closing a stake of 12 shares.

IFP Advisors first reported a position in RPRX in Q2 2016 and held it in 7 quarters. The position peaked at $0 in Q1 2018. 0 funds tracked by Wall St. Rank hold RPRX as of Q2 2018.

  • IFP Advisors reported no remaining Repros Therapeutics Inc. position as of Q2 2018 after selling out during the quarter.
  • IFP Advisors sold 12 Repros Therapeutics Inc. shares in Q2 2018.
  • IFP Advisors first reported a position in Repros Therapeutics Inc. in Q2 2016 and held it in 7 quarters.
  • IFP Advisors's Repros Therapeutics Inc. position peaked at $0 in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.